Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONDOR: 18F-DCFPyL PET/CT in Recurrent Prostate Cancer
NCT03739684Phase 3Completed
- Sponsor
- Progenics Pharmaceuticals
- Start
- Nov 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by Progenics Pharmaceuticals. Started Nov 2018; status: completed.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03739684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03739684.